Skip to main content
. Author manuscript; available in PMC: 2021 Jul 9.
Published in final edited form as: Gastroenterology. 2021 Mar 31;161(1):342–344.e1. doi: 10.1053/j.gastro.2021.03.045

Table 1.

Geographical distribution of antimicrobial resistance patterns per U.S. region, 2017-2018

Antibiotic All isolates
n=345
West
n=108
Central
n=86
East
n=151
P-value
Amoxicillin 6.4% (22) 8.3% (9) 5.8% (5) 5.3% (8) 0.6
Clarithromycin 17.4% (60) 11.1% (12) 15.1% (13) 23.2% (35) 0.03
Metronidazole 43.6% (150)* 35.5% (38)* 43.0% (37) 49.7% (75) 0.08
Rifabutin 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) ND
 
Limited Analysis
n=71
n=19 n=19 n=33
Tetracycline 2.8% (2) 5.3% (1) 5.3% (1) 0 (0.0%) 0.3
Levofloxacin 57.8% (41) 57.8% (11) 68.4% (13) 17 (51.5%) 0.5
*

Metronidazole susceptibilities were available for 107 isolates from the West region and 344 isolates in total.